A key committee at the European Parliament has called for measures to improve access to affordable medicines in Europe, such as promoting collective price negotiations, boosting the manufacture of drugs and vaccines in the EU, and setting up an early-warning system for drug shortages.
Increasing the affordability and availability of medicines “means addressing the root causes of shortages, increasing transparency on prices and public...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?